533 related articles for article (PubMed ID: 172562)
21. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
Sullender WM; Miller JL; Yasukawa LL; Bradley JS; Black SB; Yeager AS; Arvin AM
J Infect Dis; 1987 Jan; 155(1):28-37. PubMed ID: 3025306
[TBL] [Abstract][Full Text] [Related]
22. Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.
Kalimo KO; Joronen IA; Havu VK
Infect Immun; 1983 Jan; 39(1):24-8. PubMed ID: 6295957
[TBL] [Abstract][Full Text] [Related]
23. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
Nagafuchi S; Oda H; Mori R; Taniguchi T
J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
[No Abstract] [Full Text] [Related]
25. Herpes simplex virus type-2 glycoprotein-subunit vaccine: tolerance and humoral and cellular responses in humans.
Mertz GJ; Peterman G; Ashley R; Jourden JL; Salter D; Morrison L; McLean A; Corey L
J Infect Dis; 1984 Aug; 150(2):242-9. PubMed ID: 6088648
[TBL] [Abstract][Full Text] [Related]
26. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.
Farrell HE; McLean CS; Harley C; Efstathiou S; Inglis S; Minson AC
J Virol; 1994 Feb; 68(2):927-32. PubMed ID: 8289395
[TBL] [Abstract][Full Text] [Related]
27. Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines.
Bernstein DI; Stanberry LR; Kappes JC; Burke RL; Myers MG
J Infect Dis; 1988 Jun; 157(6):1178-86. PubMed ID: 2836519
[TBL] [Abstract][Full Text] [Related]
28. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
Nash AA; Ashford NP
Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
[TBL] [Abstract][Full Text] [Related]
29. Failure of systemically administered adenine arabinoside to affect humoral and cell-mediated immunity.
Zam ZS; Centifanto YM; Kaufman HE
Am J Ophthalmol; 1976 Apr; 81(4):502-5. PubMed ID: 178183
[TBL] [Abstract][Full Text] [Related]
30. Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice.
Blacklaws BA; Nash AA
J Gen Virol; 1990 Apr; 71 ( Pt 4)():863-71. PubMed ID: 2157799
[TBL] [Abstract][Full Text] [Related]
31. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus vaccines.
Wise TG; Pavan PR; Ennis FA
J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
[No Abstract] [Full Text] [Related]
33. Animal studies on the efficacy of vaccination against recurrent herpes.
Scriba M
Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
[TBL] [Abstract][Full Text] [Related]
34. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
[TBL] [Abstract][Full Text] [Related]
35. Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes.
Fujibayashi T; Hooks JJ; Notkins AL
J Immunol; 1975 Nov; 115(5):1191-3. PubMed ID: 170341
[TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.
Shimizu F; Hanaumi K; Shimizu Y; Kumagai K
Infect Immun; 1977 May; 16(2):531-6. PubMed ID: 193792
[TBL] [Abstract][Full Text] [Related]
37. Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge.
Landolfi V; Zarley CD; Abramovitz AS; Figueroa N; Wu SL; Blasiak M; Ishizaka ST; Mishkin EM
Vaccine; 1993; 11(4):407-14. PubMed ID: 8385842
[TBL] [Abstract][Full Text] [Related]
38. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.
Scriba M
Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
Jacobs RP; Aurelian L; Cole GA
J Immunol; 1976 Jun; 116(6):1520-5. PubMed ID: 58037
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.
Haahr S; Rasmussen L; Merigan TC
Infect Immun; 1976 Jul; 14(1):47-54. PubMed ID: 181328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
